The 1524% body weight reductions documented in STEP, SURMOUNT, and retatrutide Phase 2 trials far exceed any results attributed to GHRP-2, GHRP-6, or CJC-1295/ipamorelin
Glutathione deficiency leads to increased levels of oxidative stress, which might lead to cancer and other diseases
Standard dosing of 5001,000 mg every 46 hours (not exceeding 3,0004,000 mg daily) poses no known direct interaction with semaglutide's mechanism of action
Dysregulation between TH1 and TH2 T cell subpopulations in the elderly
In a recent episode of our "Health in the Headlines" series, health experts Jaime Almandoz, MD, MBA, FTOS, Govind Persad, Jeffrey Singer, and Tracy Zvenyach, PhD, MS, RN joined moderator Alex Azar, Former Secretary, US Department of Health & Human Services, to discuss what GLP-1 drugs like Ozempic, Wegovy, and Zepbound actually do, and what they dont, when it comes to obesity management, safety, cost, and access
Khavinson VK, Linkova NS, Kvetnoy IM, Kvetnaia TV, Polyakova VO, Korf H-W